Prophylactic intramuscular vitamin K administration in newborns decreased from 2017 to 2024, according to a recent research ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and ...

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...

The action follows mounting scientific evidence linking the injectable contraceptive medication to an increased risk for meningioma.

A new clinical trial demonstrates that hepatocyte growth factor plasmid therapy with AMG0001 is a promising, nonsurgical ...

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...

US FDA grants 510(k) marketing clearance to Zephyrus Innovations’ VaporShield CSTD: Vancouver, BC Wednesday, December 17, 2025, 14:00 Hrs [IST] Zephyrus Innovations (Zephyrus), ...

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...

Novo Nordisk grew its share prices by 8.96 percent week-on-week as investors cheered the approval of the Food and Drug ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private ...

Home health and personal care aides are one of the largest groups of health care workers in the US, with nearly three million people providing direct care for people with serious illness living in the ...